Abstract 821: A potent CDK7 inhibitor TY-2699a suppresses palbociclib-resistant breast cancer and has the potential for combination with chemotherapy or immunotherapy in solid tumors

Authors: Shengli Dong, Apeng Liang, Shaoqing Chen, Zhengfei Guo, Jian Zhu, Huan Wang, Jing-Lan Mu, Yakun Qi, Meihua Li, Kai Wang, Hongqiang Li, Xinlong Yang, Chao Zhou, Zhiyong He, , Mingyu Jiang, Xiugui Chen, Jun Li, Yusheng Wu

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-821

Source: Full article

---

Abstract

Introduction: